Efficacy and safety of a 4 year combination therapy of growth hormone and gonadotropin- releasing hormone agonist in children with a short predicted height.

Status: Active, no longer recruiting

Phase of Trial: Phase IV

Latest Information Update: 02 Aug 2023

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

27 Jul 2023 Planned End Date changed from 1 Apr 2023 to 1 Apr 2024.
27 Jul 2023 Planned primary completion date changed from 1 Jan 2023 to 1 Jan 2024.
23 Aug 2017 Planned End Date changed from 1 Apr 2017 to 1 Apr 2023.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com